Cargando…
Regulatory Aspects of Clinical Trials in Iran: Third Year Report of Clinical Trial Committee in Food and Drug Organization
BACKGROUND: Clinical Trial Committee (CTC) has been established in Food and Drug Organization (FDO), in 2003 to assure efficacy and safety of all types of medicinal products which are meant to be registered in Iran Drug List and/or obtain market authorization. METHODS: All clinical trial files, meet...
Autores principales: | HOSSEINI, Seyed Ali Reza, DARBOOY, Shadan, SALIMI, Akram |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Tehran University of Medical Sciences
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3595621/ https://www.ncbi.nlm.nih.gov/pubmed/23515424 |
Ejemplares similares
-
A third trial oversight committee: Functions, benefits and issues
por: Lane, J Athene, et al.
Publicado: (2019) -
Evaluation of chemical and microbial quality of food in northern Iran
por: Aghalari, Zahra, et al.
Publicado: (2021) -
Regulatory Aspects in Using Surrogate Markers in Clinical Trials
por: Chakravarty, Aloka
Publicado: (2005) -
A Comparison Study of Efficacy and Safety of a Biosimilar Form of Intramuscular Βeta-interferon I-a Versus the Reference Product: A Randomized Controlled Clinical Trial in Iran
por: Nabavi, Seyed Massood, et al.
Publicado: (2019) -
Clinical and molecular aspects of human pegiviruses in the interaction host and infectious agent
por: Samadi, Mehdi, et al.
Publicado: (2022)